304 related articles for article (PubMed ID: 23635816)
1. Mutation status of the mediator complex subunit 12 (MED12) in uterine leiomyomas and concurrent/metachronous multifocal peritoneal smooth muscle nodules (leiomyomatosis peritonealis disseminata).
Rieker RJ; Agaimy A; Moskalev EA; Hebele S; Hein A; Mehlhorn G; Beckmann MW; Hartmann A; Haller F
Pathology; 2013 Jun; 45(4):388-92. PubMed ID: 23635816
[TBL] [Abstract][Full Text] [Related]
2. MED12 exon 2 mutation is uncommon in intravenous leiomyomatosis: clinicopathologic features and molecular study.
Wang L; Hu S; Xin F; Zhao H; Li G; Ran W; Xing X; Wang J
Hum Pathol; 2020 May; 99():36-42. PubMed ID: 32240666
[TBL] [Abstract][Full Text] [Related]
3. MED12 exon 2 mutations in uterine and extrauterine smooth muscle tumors.
Schwetye KE; Pfeifer JD; Duncavage EJ
Hum Pathol; 2014 Jan; 45(1):65-70. PubMed ID: 24196187
[TBL] [Abstract][Full Text] [Related]
4. A clinicopathological and molecular analysis in uterine leiomyomas and concurrent/metachronous peritoneal nodules: New insights into disseminated peritoneal leiomyomatosis.
Ma Y; Wang S; Liu Q; Lu B
Pathol Res Pract; 2020 May; 216(5):152938. PubMed ID: 32234244
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of MED12 mutations in uterine and extrauterine smooth muscle tumours.
Matsubara A; Sekine S; Yoshida M; Yoshida A; Taniguchi H; Kushima R; Tsuda H; Kanai Y
Histopathology; 2013 Mar; 62(4):657-61. PubMed ID: 23347103
[TBL] [Abstract][Full Text] [Related]
6. MED12 and uterine smooth muscle oncogenesis: State of the art and perspectives.
Croce S; Chibon F
Eur J Cancer; 2015 Aug; 51(12):1603-10. PubMed ID: 26037152
[TBL] [Abstract][Full Text] [Related]
7. Characterization of MED12, HMGA2, and FH alterations reveals molecular variability in uterine smooth muscle tumors.
Mäkinen N; Kämpjärvi K; Frizzell N; Bützow R; Vahteristo P
Mol Cancer; 2017 Jun; 16(1):101. PubMed ID: 28592321
[TBL] [Abstract][Full Text] [Related]
8. Frequency and Spectrum of MED12 Exon 2 Mutations in Multiple Versus Solitary Uterine Leiomyomas From Russian Patients.
Osinovskaya NS; Malysheva OV; Shved NY; Ivashchenko TE; Sultanov IY; Efimova OA; Yarmolinskaya MI; Bezhenar VF; Baranov VS
Int J Gynecol Pathol; 2016 Nov; 35(6):509-515. PubMed ID: 26630226
[TBL] [Abstract][Full Text] [Related]
9. Whole exome sequencing in a random sample of North American women with leiomyomas identifies MED12 mutations in majority of uterine leiomyomas.
McGuire MM; Yatsenko A; Hoffner L; Jones M; Surti U; Rajkovic A
PLoS One; 2012; 7(3):e33251. PubMed ID: 22428002
[TBL] [Abstract][Full Text] [Related]
10. MED12 mutations and FH inactivation are mutually exclusive in uterine leiomyomas.
Kämpjärvi K; Mäkinen N; Mehine M; Välipakka S; Uimari O; Pitkänen E; Heinonen HR; Heikkinen T; Tolvanen J; Ahtikoski A; Frizzell N; Sarvilinna N; Sjöberg J; Bützow R; Aaltonen LA; Vahteristo P
Br J Cancer; 2016 Jun; 114(12):1405-11. PubMed ID: 27187686
[TBL] [Abstract][Full Text] [Related]
11. Selected case from the Arkadi M. Rywlin International Pathology Slide Series: Leiomyomatosis peritonealis disseminata: report of 3 cases with extensive review of the literature.
Bisceglia M; Galliani CA; Pizzolitto S; Ben-Dor D; Giannatempo G; Bergoli AL; Aieta M
Adv Anat Pathol; 2014 May; 21(3):201-15. PubMed ID: 24713991
[TBL] [Abstract][Full Text] [Related]
12. Successful pregnancy after complete resection of leiomyomatosis peritonealis disseminate without recurrence:a case report with next-generation sequencing analysis and literature review.
Bu H; Jin C; Fang Y; Ma Y; Wang X; Chen J; Chen L
World J Surg Oncol; 2020 May; 18(1):85. PubMed ID: 32359372
[TBL] [Abstract][Full Text] [Related]
13. MED12 alterations in both human benign and malignant uterine soft tissue tumors.
Pérot G; Croce S; Ribeiro A; Lagarde P; Velasco V; Neuville A; Coindre JM; Stoeckle E; Floquet A; MacGrogan G; Chibon F
PLoS One; 2012; 7(6):e40015. PubMed ID: 22768200
[TBL] [Abstract][Full Text] [Related]
14. Mediator complex subunit 12 exon 2 mutation analysis in different subtypes of smooth muscle tumors confirms genetic heterogeneity.
de Graaff MA; Cleton-Jansen AM; Szuhai K; Bovée JV
Hum Pathol; 2013 Aug; 44(8):1597-604. PubMed ID: 23517922
[TBL] [Abstract][Full Text] [Related]
15. Leiomyomatosis peritonealis disseminata of unusual course with malignant transformation: case report.
Żyła MM; Dzieniecka M; Kostrzewa M; Stetkiewicz T; Wilamowska A; Księżakowska-Łakoma K; Wilczyński JR
Acta Obstet Gynecol Scand; 2015 Feb; 94(2):220-3. PubMed ID: 25546607
[TBL] [Abstract][Full Text] [Related]
16. [Minimally invasive therapy of peritoneal leiomyomatosis. A case report of diagnostic and therapeutic problems].
Kruczynski D; Merz E; Beck T; Bahlmann F; Wilkens C; Weber G; Macchiella D; Knapstein PG
Geburtshilfe Frauenheilkd; 1994 Mar; 54(3):181-3. PubMed ID: 8188020
[TBL] [Abstract][Full Text] [Related]
17. Exomic landscape of MED12 mutation-negative and -positive uterine leiomyomas.
Mäkinen N; Vahteristo P; Bützow R; Sjöberg J; Aaltonen LA
Int J Cancer; 2014 Feb; 134(4):1008-12. PubMed ID: 23913526
[TBL] [Abstract][Full Text] [Related]
18. MED12 and HMGA2 mutations: two independent genetic events in uterine leiomyoma and leiomyosarcoma.
Bertsch E; Qiang W; Zhang Q; Espona-Fiedler M; Druschitz S; Liu Y; Mittal K; Kong B; Kurita T; Wei JJ
Mod Pathol; 2014 Aug; 27(8):1144-53. PubMed ID: 24390224
[TBL] [Abstract][Full Text] [Related]
19. Leiomyomatosis peritonealis disseminata: does malignant transformation occur? A literature review.
Bekkers RL; Willemsen WN; Schijf CP; Massuger LF; Bulten J; Merkus JM
Gynecol Oncol; 1999 Oct; 75(1):158-63. PubMed ID: 10502446
[TBL] [Abstract][Full Text] [Related]
20. Multiple clinical characteristics separate MED12-mutation-positive and -negative uterine leiomyomas.
Heinonen HR; Pasanen A; Heikinheimo O; Tanskanen T; Palin K; Tolvanen J; Vahteristo P; Sjöberg J; Pitkänen E; Bützow R; Mäkinen N; Aaltonen LA
Sci Rep; 2017 Apr; 7(1):1015. PubMed ID: 28432313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
